273 related articles for article (PubMed ID: 24529672)
1. Targeting the cannabinoid system for pain relief?
Chiou LC; Hu SS; Ho YC
Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
[TBL] [Abstract][Full Text] [Related]
2. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
Gregg LC; Jung KM; Spradley JM; Nyilas R; Suplita RL; Zimmer A; Watanabe M; Mackie K; Katona I; Piomelli D; Hohmann AG
J Neurosci; 2012 Jul; 32(28):9457-68. PubMed ID: 22787031
[TBL] [Abstract][Full Text] [Related]
3. Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation.
Bouchet CA; McPherson KB; Coutens B; Janowsky A; Ingram SL
J Neurosci; 2023 Jul; 43(30):5458-5467. PubMed ID: 37414560
[TBL] [Abstract][Full Text] [Related]
4. Critical enzymes involved in endocannabinoid metabolism.
Basavarajappa BS
Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism and Cannabinoid Pharmacology.
Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway.
Winters BL; Lau BK; Vaughan CW
J Neurosci; 2022 Oct; 42(41):7744-7756. PubMed ID: 36414010
[TBL] [Abstract][Full Text] [Related]
7. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
Anand P; Whiteside G; Fowler CJ; Hohmann AG
Brain Res Rev; 2009 Apr; 60(1):255-66. PubMed ID: 19150370
[TBL] [Abstract][Full Text] [Related]
8.
Klawitter J; Weissenborn W; Gvon I; Walz M; Klawitter J; Jackson M; Sempio C; Joksimovic SL; Shokati T; Just I; Christians U; Todorovic SM
Mol Pharmacol; 2024 Jan; 105(2):75-83. PubMed ID: 38195158
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.
Mukhopadhyay S; Tulis DA
Cardiovasc Hematol Agents Med Chem; 2007 Oct; 5(4):311-8. PubMed ID: 17979695
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis for neuroimmune receptor signaling.
Rogers TJ
J Neuroimmune Pharmacol; 2012 Dec; 7(4):722-4. PubMed ID: 22935971
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic signature, bioactivity and safety of a non-hepatotoxic analgesic generating AM404 in the midbrain PAG region.
Bazan HA; Bhattacharjee S; Reid MM; Jun B; Polk C; Strain M; St Pierre LA; Desai N; Daly PW; Cucinello-Ragland JA; Edwards S; Recio J; Alvarez-Builla J; Cai JJ; Bazan NG
Sci Rep; 2024 May; 14(1):11103. PubMed ID: 38750093
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.
Rodriguez-Sanchez IP; Guindon J; Ruiz M; Tejero ME; Hubbard G; Martinez-de-Villarreal LE; Barrera-Saldaña HA; Dick EJ; Comuzzie AG; Schlabritz-Loutsevitch NE
Neurotoxicol Teratol; 2016; 58():23-30. PubMed ID: 27327781
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.
Jhaveri MD; Richardson D; Chapman V
Br J Pharmacol; 2007 Nov; 152(5):624-32. PubMed ID: 17704819
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling.
Stachowicz K
Neurosci Biobehav Rev; 2023 Dec; 155():105439. PubMed ID: 37898448
[TBL] [Abstract][Full Text] [Related]
15. CB2 receptors in reproduction.
Maccarrone M
Br J Pharmacol; 2008 Jan; 153(2):189-98. PubMed ID: 17828289
[TBL] [Abstract][Full Text] [Related]
16. Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests.
Brianis RC; Lima RC; Moreira FA; Aguiar DC
Behav Pharmacol; 2022 Apr; 33(2&3):213-221. PubMed ID: 34074811
[TBL] [Abstract][Full Text] [Related]
17. A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence.
Jiang M; Huizenga MCW; Wirt JL; Paloczi J; Amedi A; van den Berg RJBHN; Benz J; Collin L; Deng H; Di X; Driever WF; Florea BI; Grether U; Janssen APA; Hankemeier T; Heitman LH; Lam TW; Mohr F; Pavlovic A; Ruf I; van den Hurk H; Stevens AF; van der Vliet D; van der Wel T; Wittwer MB; van Boeckel CAA; Pacher P; Hohmann AG; van der Stelt M
Nat Commun; 2023 Dec; 14(1):8039. PubMed ID: 38052772
[TBL] [Abstract][Full Text] [Related]
18. Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.
Lee MT; Mackie K; Chiou LC
Br J Pharmacol; 2023 Apr; 180(7):894-909. PubMed ID: 34877650
[TBL] [Abstract][Full Text] [Related]
19. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.
Cabral GA; Rogers TJ; Lichtman AH
J Neuroimmune Pharmacol; 2015 Jun; 10(2):193-203. PubMed ID: 26054900
[TBL] [Abstract][Full Text] [Related]
20. 2-Arachidonoylglycerol-mediated endocannabinoid signaling modulates mechanical hypersensitivity associated with alcohol withdrawal in mice.
Morgan A; Adank D; Johnson K; Butler E; Patel S
Alcohol Clin Exp Res; 2022 Nov; 46(11):2010-2024. PubMed ID: 36125319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
